Cite
HARVARD Citation
Feagan, B. et al. (n.d.). P-100 Improvement in Quality of Life as a Predictor of Long-Term Remission in Crohn's Disease Patients Treated with Certolizumab Pegol. Inflammatory bowel diseases. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feagan, B. et al. (n.d.). P-100 Improvement in Quality of Life as a Predictor of Long-Term Remission in Crohn's Disease Patients Treated with Certolizumab Pegol. Inflammatory bowel diseases. p. . [Online].